Merck KGaA (FRA:MRK) has been assigned a €109.00 ($119.78) price objective by Commerzbank Ag in a report released on Friday. The firm presently has a “neutral” rating on the healthcare company’s stock.

Other research analysts have also recently issued reports about the stock. equinet AG set a €91.00 ($100.00) price target on shares of Merck KGaA and gave the company a “neutral” rating in a research report on Tuesday, April 25th. Warburg Research set a €114.00 ($125.27) price target on shares of Merck KGaA and gave the company a “buy” rating in a research report on Monday, March 20th. HSBC Holdings plc set a €95.00 ($104.40) price target on shares of Merck KGaA and gave the company a “neutral” rating in a research report on Monday, March 13th. Citigroup Inc set a €116.00 ($127.47) target price on shares of Merck KGaA and gave the stock a “buy” rating in a research report on Wednesday, March 1st. Finally, Morgan Stanley set a €103.00 ($113.19) target price on shares of Merck KGaA and gave the stock a “neutral” rating in a research report on Monday. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and six have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of €109.29 ($120.09).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Merck KGaA (FRA:MRK) traded down 0.555% during mid-day trading on Friday, hitting €107.898. 890 shares of the stock traded hands. Merck KGaA has a 12-month low of €80.99 and a 12-month high of €115.00. The firm’s 50-day moving average is €107.69 and its 200-day moving average is €101.54. The company has a market cap of €46.91 billion and a price-to-earnings ratio of 28.796.

TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/05/19/commerzbank-ag-analysts-give-merck-kgaa-mrk-a-109-00-price-target.html.

About Merck KGaA

.

12 Month Chart for FRA:MRK

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.